SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $503,217 | +6.4% | 3,651 | +0.0% | 0.06% | +5.2% |
Q4 2022 | $472,967 | +17.4% | 3,650 | 0.0% | 0.06% | +3.6% |
Q3 2022 | $403,000 | +47.1% | 3,650 | 0.0% | 0.06% | +60.0% |
Q2 2022 | $274,000 | -3.9% | 3,650 | 0.0% | 0.04% | +9.4% |
Q1 2022 | $285,000 | -38.4% | 3,650 | -35.4% | 0.03% | -41.8% |
Q4 2021 | $463,000 | +24.5% | 5,650 | +18.0% | 0.06% | +12.2% |
Q3 2021 | $372,000 | -11.4% | 4,790 | -11.3% | 0.05% | -15.5% |
Q2 2021 | $420,000 | +40.9% | 5,400 | +35.0% | 0.06% | +16.0% |
Q1 2021 | $298,000 | -55.7% | 4,000 | +1.3% | 0.05% | -60.9% |
Q4 2020 | $673,000 | -35.7% | 3,950 | -47.0% | 0.13% | -46.7% |
Q3 2020 | $1,046,000 | – | 7,450 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |